|
US5994392A
(en)
|
1988-02-26 |
1999-11-30 |
Neuromedica, Inc. |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
EP0870510A3
(en)
*
|
1997-04-11 |
1999-09-15 |
Eli Lilly And Company |
Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents
|
|
WO1999049848A1
(en)
*
|
1998-04-01 |
1999-10-07 |
Rtp Pharma Inc. |
Anticancer compositions
|
|
DE19842415A1
(de)
*
|
1998-09-16 |
2000-03-23 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung
|
|
US6380183B1
(en)
*
|
1998-12-18 |
2002-04-30 |
Scios, Inc. |
Treatment of diseases involving cyst formation
|
|
US7235583B1
(en)
*
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
|
KR20020000147A
(ko)
*
|
1999-03-09 |
2002-01-04 |
니겔 엘. 웹 |
지방산-항암제 결합체 및 그의 용도
|
|
EP1229934B1
(en)
|
1999-10-01 |
2014-03-05 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US7303749B1
(en)
*
|
1999-10-01 |
2007-12-04 |
Immunogen Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US6890946B2
(en)
*
|
1999-12-23 |
2005-05-10 |
Indiana University Research And Technology Corporation |
Use of parthenolide to inhibit cancer
|
|
US6660750B2
(en)
|
2000-02-15 |
2003-12-09 |
University Of Iowa Research Foundation |
Flavopiridol methods and compositions for HIV therapy
|
|
WO2001064199A2
(en)
*
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with taxane compounds
|
|
DE10012120A1
(de)
*
|
2000-03-13 |
2001-09-27 |
Ktb Tumorforschungs Gmbh |
Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
AU2001247726A1
(en)
*
|
2000-03-24 |
2001-10-08 |
Baker Norton Pharmaceuticals, Inc. |
Taxane-based compositions and methods of use
|
|
EP2298355A3
(en)
|
2000-04-12 |
2011-06-29 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
AU7007001A
(en)
|
2000-06-22 |
2002-01-02 |
Nitromed Inc |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
AU2002222931A1
(en)
|
2000-07-19 |
2002-01-30 |
University Of Pittsburgh |
Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a
|
|
US6696488B2
(en)
|
2000-08-11 |
2004-02-24 |
The Brigham And Women's Hospital, Inc. |
(Hydroxyethyl)ureas as inhibitors of alzheimer's β-amyloid production
|
|
US20040253891A1
(en)
*
|
2000-09-12 |
2004-12-16 |
Schierenbeck Alan W. |
Composite structure for protective garment
|
|
US20040091509A1
(en)
*
|
2000-12-14 |
2004-05-13 |
Avon Products, Inc. |
Skin care composition that mediates cell to cell communication
|
|
US7037906B1
(en)
*
|
2000-12-22 |
2006-05-02 |
Oxigene, Inc. |
Methods for modulating tumor growth and metastasis
|
|
US20050209310A1
(en)
*
|
2000-12-22 |
2005-09-22 |
Chaplin David J |
Methods for modulating tumor growth and metastasis
|
|
JP2005500988A
(ja)
*
|
2001-03-23 |
2005-01-13 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪族アミン薬物複合体
|
|
EP1423107B1
(en)
*
|
2001-03-23 |
2012-05-09 |
Luitpold Pharmaceuticals, Inc. |
Fatty alcohol drug conjugates
|
|
UY27304A1
(es)
*
|
2001-05-24 |
2002-12-31 |
Avanir Pharmaceuticals |
Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
|
|
AU2002310122A1
(en)
*
|
2001-05-25 |
2002-12-09 |
Human Genome Sciences, Inc. |
Chemokine beta-1 fusion proteins
|
|
DE10142881A1
(de)
*
|
2001-09-03 |
2003-04-03 |
Jomed Gmbh |
Implantate mit Combretastatin A-4 (CA4)
|
|
AU2002352982B2
(en)
*
|
2001-11-29 |
2008-03-06 |
Sound Pharmaceuticals Incorporated |
Methods and compositions for ameliorating the undesirable effects of chemotherapy
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
WO2005003296A2
(en)
|
2003-01-22 |
2005-01-13 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
NZ538498A
(en)
*
|
2002-07-30 |
2009-02-28 |
Childrens Medical Center |
Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
|
|
US7161003B1
(en)
|
2002-09-04 |
2007-01-09 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7205308B2
(en)
*
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
KR20050033659A
(ko)
*
|
2002-09-04 |
2005-04-12 |
쉐링 코포레이션 |
사이클린 의존성 키나제 억제제로서의 피라졸로[1,5-ａ]피리미딘 화합물
|
|
US7196078B2
(en)
*
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7119200B2
(en)
*
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
CN1694705A
(zh)
*
|
2002-09-04 |
2005-11-09 |
先灵公司 |
用作依赖细胞周期蛋白激酶抑制剂的吡唑并嘧啶
|
|
ES2291665T3
(es)
*
|
2002-09-04 |
2008-03-01 |
Schering Corporation |
Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas.
|
|
CA2497444C
(en)
|
2002-09-04 |
2010-11-30 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
JP5354836B2
(ja)
*
|
2002-11-06 |
2013-11-27 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
プロテアソームインヒビターを使用する癌を処置するための方法および組成物
|
|
TW200418829A
(en)
*
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
|
WO2004091594A1
(en)
*
|
2003-04-15 |
2004-10-28 |
Institut National De La Sante Et De La Recherche Medicale |
Use of geraniol in antitumoral therapy
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
US8092787B2
(en)
*
|
2003-05-22 |
2012-01-10 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent
|
|
US20050143371A1
(en)
*
|
2003-07-23 |
2005-06-30 |
Pharmacia Corporation |
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
|
|
US20050107350A1
(en)
*
|
2003-08-22 |
2005-05-19 |
Pharmacia Corporation |
Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
|
|
US20050187278A1
(en)
*
|
2003-08-28 |
2005-08-25 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
|
|
US6949895B2
(en)
*
|
2003-09-03 |
2005-09-27 |
Axcelis Technologies, Inc. |
Unipolar electrostatic quadrupole lens and switching methods for charged beam transport
|
|
US20050148534A1
(en)
*
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
|
TW200522978A
(en)
*
|
2003-10-29 |
2005-07-16 |
Sonus Pharma Inc |
Tocopherol-modified therapeutic drug compounds
|
|
AU2004285529A1
(en)
*
|
2003-10-30 |
2005-05-12 |
The Research Foundation of University of New York York |
Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
|
|
WO2005046676A1
(en)
*
|
2003-11-12 |
2005-05-26 |
University Of South Carolina |
Treatment or prevention of cardiovascular and respiratory disorders with novel substituted cyclic amp-specific phosphodiesterase inhibitors
|
|
US7501397B2
(en)
*
|
2004-06-04 |
2009-03-10 |
The Brigham And Women's Hospital, Inc. |
Helical peptidomimetics with enhanced activity
|
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
US8080560B2
(en)
*
|
2004-12-17 |
2011-12-20 |
3M Innovative Properties Company |
Immune response modifier formulations containing oleic acid and methods
|
|
CN101160121B
(zh)
*
|
2005-03-08 |
2012-05-23 |
桑得医药品公司 |
治疗癌症的组合物
|
|
CA2600175A1
(en)
*
|
2005-03-24 |
2006-03-20 |
Avanir Pharmaceuticals |
Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
|
|
JP4954983B2
(ja)
|
2005-05-18 |
2012-06-20 |
ファーマサイエンス・インコーポレイテッド |
Ｂｉｒドメイン結合化合物
|
|
US20070142457A1
(en)
*
|
2005-10-12 |
2007-06-21 |
Alessandro Pontiroli |
Crystalline forms of docetaxel and processes for their preparation
|
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
GB0605689D0
(en)
*
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic compounds
|
|
JP5419685B2
(ja)
|
2006-05-16 |
2014-02-19 |
ファーマサイエンス・インコーポレイテッド |
Ｉａｐｂｉｒドメイン結合タンパク質
|
|
FR2902659A1
(fr)
*
|
2006-06-23 |
2007-12-28 |
Pierre Fabre Medicament Sa |
Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
|
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8173686B2
(en)
|
2006-11-06 |
2012-05-08 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
CA2687291A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Ktb Tumorforschungsgesellschaft Mbh |
Low-viscous anthracycline formulation
|
|
WO2008151253A1
(en)
*
|
2007-06-04 |
2008-12-11 |
Threshold Pharmaceuticals, Inc. |
Hypoxia activated prodrugs of antineoplastic agents
|
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
CN101809024A
(zh)
*
|
2007-07-16 |
2010-08-18 |
铂雅制药公司 |
吡铂的口服制剂
|
|
WO2009042766A1
(en)
*
|
2007-09-26 |
2009-04-02 |
Mount Sinai School Of Medicine |
Azacytidine analogues and uses thereof
|
|
CN102014624A
(zh)
*
|
2008-02-08 |
2011-04-13 |
帕纳德制药公司 |
治疗肺癌的吡铂和氨柔比星
|
|
BRPI0906181A2
(pt)
|
2008-03-18 |
2015-06-30 |
Genentech Inc |
"método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer"
|
|
JP2012520298A
(ja)
*
|
2009-03-12 |
2012-09-06 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
Ｇａｂａに結合したアントラサイクリン−脂質複合体
|
|
MX340870B
(es)
|
2010-02-12 |
2016-07-27 |
Pharmascience Inc |
Compuestos de unión del dominio de repetición de inhibidores de proteínas de apoptosis de baculovirus.
|
|
PL226015B1
(pl)
|
2011-03-03 |
2017-06-30 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną |
Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
|
|
WO2015153345A1
(en)
|
2014-04-03 |
2015-10-08 |
Invictus Oncology Pvt. Ltd. |
Supramolecular combinatorial therapeutics
|
|
JP2019522032A
(ja)
|
2016-07-29 |
2019-08-08 |
ヤンセン ファーマシューティカ エヌ．ベー． |
前立腺癌の治療方法
|
|
WO2019126302A2
(en)
*
|
2017-12-20 |
2019-06-27 |
Targagenix, Inc. |
Combination taxoid nanoemulsion with immunotherapy in cancer
|
|
IL320853A
(en)
|
2022-11-21 |
2025-07-01 |
Segena Corp S A |
Improving the immunomodulatory activity of oligonucleotides through long-term modification of dianophor: methods and applications
|